Mechanisms of obesity-induced hypertension.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 20442753)

Published in Hypertens Res on May 01, 2010

Authors

Vasilios Kotsis1, Stella Stabouli, Sofia Papakatsika, Zoe Rizos, Gianfranco Parati

Author Affiliations

1: 3rd Department of Medicine, Hypertension Center, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Articles citing this

Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes (2014) 1.85

Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study. J Hypertens (2016) 1.40

Associations of Infant Feeding and Timing of Weight Gain and Linear Growth during Early Life with Childhood Blood Pressure: Findings from a Prospective Population Based Cohort Study. PLoS One (2016) 1.39

Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21

Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study. Arch Med Sci (2012) 1.17

Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities. Am J Physiol Regul Integr Comp Physiol (2011) 1.12

Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta (2012) 1.08

The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol (2012) 1.07

Overweight in childhood, adolescence and adulthood and cardiovascular risk in later life: pooled analysis of three british birth cohorts. PLoS One (2013) 1.06

Association between adiposity indices and cardiometabolic risk factors among adults living in Puerto Rico. Public Health Nutr (2011) 1.02

Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens (2011) 1.00

Blood pressure and associated factors in a North African adolescent population. a national cross-sectional study in Tunisia. BMC Public Health (2012) 0.96

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation. Diabetes Metab Syndr Obes (2010) 0.92

The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. Biomed Res Int (2014) 0.91

Resting heart rate as a predictor of metabolic dysfunctions in obese children and adolescents. BMC Pediatr (2012) 0.90

Differential effects of cystathionine-γ-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas. PLoS One (2012) 0.89

Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol (2015) 0.89

Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine. Neuroimage (2013) 0.89

Body mass index contributes to sympathovagal imbalance in prehypertensives. BMC Cardiovasc Disord (2012) 0.88

Blood pressure relation to body composition and age: analysis of a nurse-led investigation and consultation program. Med Sci Monit (2013) 0.86

Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature. J Physiol (2011) 0.85

Adipocyte dysfunction and hypertension. Am J Cardiovasc Dis (2012) 0.85

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia. J Res Med Sci (2012) 0.85

Sympathovagal Imbalance in Prehypertensive Offspring of Two Parents versus One Parent Hypertensive. Int J Hypertens (2011) 0.84

Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats. PLoS One (2013) 0.84

Cardiac insulin resistance and microRNA modulators. Exp Diabetes Res (2011) 0.84

Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study. Hypertension (2015) 0.83

Hydrogen sulfide: potent regulator of vascular tone and stimulator of angiogenesis. Int J Biomed Sci (2012) 0.83

Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome. Hypertens Res (2015) 0.83

High fat feeding impairs endothelin-1 mediated vasoconstriction through increased iNOS-derived nitric oxide. Horm Metab Res (2011) 0.83

Correlation of visceral adiposity index with chronic kidney disease in the People's Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity. Ther Clin Risk Manag (2016) 0.83

Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells. BMC Cell Biol (2013) 0.83

Early Weight Gain, Linear Growth, and Mid-Childhood Blood Pressure: A Prospective Study in Project Viva. Hypertension (2015) 0.82

Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. Br J Pharmacol (2014) 0.80

Primary hypertension and special aspects of hypertension in older children and adolescents. Adolesc Health Med Ther (2011) 0.80

Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension (2015) 0.80

The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo) (2013) 0.80

Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women. Int J Epidemiol (2015) 0.79

Leptin signaling molecular actions and drug target in hepatocellular carcinoma. Drug Des Devel Ther (2014) 0.79

Energy Drinks and Their Impact on the Cardiovascular System: Potential Mechanisms. Adv Nutr (2016) 0.78

6-Minute Walk Test Performance in Young Children who are Normal Weight and Overweight. Cardiopulm Phys Ther J (2012) 0.78

Insulin Signaling and Heart Failure. Circ Res (2016) 0.78

Relationships of Dietary Histidine and Obesity in Northern Chinese Adults, an Internet-Based Cross-Sectional Study. Nutrients (2016) 0.78

A functional variant of NEDD4L is associated with obesity and related phenotypes in a Han population of Southern China. Int J Mol Sci (2013) 0.78

Gender and obesity modify the impact of salt intake on blood pressure in children. Pediatr Nephrol (2015) 0.77

Maternal Prenatal Mental Health and Placental 11β-HSD2 Gene Expression: Initial Findings from the Mercy Pregnancy and Emotional Wellbeing Study. Int J Mol Sci (2015) 0.76

Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486. Nutr Diabetes (2016) 0.76

Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy. Front Physiol (2016) 0.76

Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome. PLoS One (2015) 0.76

The Different Effects of BMI and WC on Organ Damage in Patients from a Cardiac Rehabilitation Program after Acute Coronary Syndrome. Biomed Res Int (2015) 0.75

Treatment strategies to prevent renal damage in hypertensive children. Curr Hypertens Rep (2014) 0.75

High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. Am J Physiol Endocrinol Metab (2015) 0.75

Different effect of alcohol consumption on hypertension according to metabolic health status. J Hum Hypertens (2015) 0.75

Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity. J Diabetes Res (2017) 0.75

Left Ventricular Diastolic Dysfunction Assessed by Conventional Echocardiography and Spectral Tissue Doppler Imaging in Adolescents With Arterial Hypertension. Medicine (Baltimore) (2016) 0.75

Predicting increased blood pressure using machine learning. J Obes (2014) 0.75

An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy. Int J Hypertens (2016) 0.75

Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review. BMJ Open (2014) 0.75

Clinical utility of valsartan in treatment of children and adolescents with high blood pressure. Adolesc Health Med Ther (2011) 0.75

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans. J Appl Physiol (1985) (2010) 0.75

Adiposity and Blood Pressure in 110 000 Mexican Adults. Hypertension (2017) 0.75

Pathophysiology and Medical Treatment of Carotid Artery Stenosis. Int J Angiol (2015) 0.75

Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects. J Nutr Sci (2012) 0.75

Antiobesity and Antidiabetes Effects of a Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential. Biomed Res Int (2016) 0.75

Screening, diagnosis and treatment of hypertension in obese children: an international policy comparison. J Nephrol (2016) 0.75

The need for noninvasive methods to monitor hemodynamics in hypertension therapy. Hypertens Res (2016) 0.75

Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients. Pediatr Nephrol (2015) 0.75

Performance of waist circumference and proposed cutoff levels for defining overweight and obesity in Nigerians. Ann Afr Med (2016) 0.75

Articles by these authors

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94

European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28

Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit (2002) 4.02

Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15

Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension (2007) 2.93

Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71

Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. Hypertension (2011) 2.52

European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit (2010) 2.42

Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension (2013) 2.30

ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24

Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation (2012) 2.21

Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation (2012) 2.13

Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension (2005) 2.05

Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02

Hypertension and reduced renal function in an 83-year-old patient. Intern Emerg Med (2006) 1.92

Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension (2005) 1.88

Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens (2003) 1.74

Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens (2004) 1.69

Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens (2008) 1.66

Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. J Hypertens (2011) 1.66

How to assess mean blood pressure properly at the brachial artery level. J Hypertens (2007) 1.61

Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation (2006) 1.54

Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. BMJ (2010) 1.53

Obesity and daytime pulse pressure are predictors of left ventricular hypertrophy in true normotensive individuals. J Hypertens (2010) 1.52

Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol (2003) 1.51

MagIC System: a New Textile-Based Wearable Device for Biological Signal Monitoring. Applicability in Daily Life and Clinical Setting. Conf Proc IEEE Eng Med Biol Soc (2005) 1.50

Effects of salt sensitivity on neural cardiovascular regulation in essential hypertension. Hypertension (2005) 1.48

Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47

Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens (2007) 1.42

Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure - Application of Metabolic Exercise Cardiac Kidney Indexes Score. Circ J (2015) 1.42

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42

Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens (2013) 1.42

Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis. J Endovasc Ther (2013) 1.40

Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. Int J Cardiol (2013) 1.40

Effects of device-guided slow breathing training on exercise capacity, cardiac function and respiratory patterns during sleep in male and female patients with chronic heart failure. Pol Arch Med Wewn (2017) 1.39

Long-term blood pressure changes induced by the 2009 L'Aquila earthquake: assessment by 24 h ambulatory monitoring. Hypertens Res (2013) 1.39

Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood (2010) 1.37

Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension (2005) 1.30

A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens (2007) 1.22

Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens (2004) 1.19

Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19

Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare (2008) 1.17

Self monitoring of blood pressure at home. BMJ (2004) 1.14

Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2002) 1.13

Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens (2013) 1.12

Stress reduction and blood pressure control in hypertension: a role for transcendental meditation? J Hypertens (2004) 1.11

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology (2011) 1.11

Prevalence of home blood pressure measurement among selected hypertensive patients: results of a multicenter survey from six hospital outpatient hypertension clinics in Italy. Blood Press (2005) 1.09

Variables influencing heart rate. Prog Cardiovasc Dis (2009) 1.09

Scale exponents of blood pressure and heart rate during autonomic blockade as assessed by detrended fluctuation analysis. J Physiol (2010) 1.09

Self blood pressure monitoring at home by wrist devices: a reliable approach? J Hypertens (2002) 1.09

Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens (2012) 1.09

Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens (2006) 1.09

Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res (2008) 1.08

International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol (2013) 1.05

Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia. Neuropsychopharmacology (2006) 1.05

Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04

When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens (2003) 1.04

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens (2014) 1.03

Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens (2008) 1.03

Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit (2007) 1.02

Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol (2012) 1.02

The role of blood pressure variability in end-organ damage. J Hypertens Suppl (2003) 1.02

Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation (2009) 1.01

Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension (2005) 1.01

Assessing arterial baroreflex control of heart rate: new perspectives. J Hypertens (2004) 1.00

Ambulatory blood pressure measurement: what is the international consensus? Hypertension (2013) 0.99

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens (2002) 0.99

Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol (2009) 0.98

Home blood pressure monitoring in clinical practice: how many measurements and when? J Hypertens (2007) 0.97

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens (2006) 0.97

Day-night blood pressure variations: mechanisms, reproducibility and clinical relevance. J Hypertens (2007) 0.97

Impact of home patient telemonitoring on use of β-blockers in congestive heart failure. Drugs Aging (2010) 0.96

How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability. Hypertension (2011) 0.96

Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens (2016) 0.95

Wearable seismocardiography. Conf Proc IEEE Eng Med Biol Soc (2007) 0.94

Mechanisms of blood pressure and heart rate variability: an insight from low-level paraplegia. Am J Physiol Regul Integr Comp Physiol (2006) 0.94

The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93

Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol Dial Transplant (2013) 0.93

Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension (2003) 0.93

Sleep apnoea and the heart. Eur Respir Rev (2013) 0.92

Self measured and ambulatory blood pressure in assessing the 'white-coat' phenomenon. J Hypertens (2003) 0.92

A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory. Behav Brain Res (2008) 0.92

Early vascular aging and the role of central blood pressure. J Hypertens (2011) 0.92

White coat effect: semantics, assessment and pathophysiological implications. J Hypertens (2003) 0.92

Continuous positive airway pressure increases haemoglobin O2 saturation after acute but not prolonged altitude exposure. Eur Heart J (2009) 0.91

Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit (2008) 0.91

Seasonal variations in blood pressure: a complex phenomenon. J Hypertens (2012) 0.91

Assessment of the autonomic control of heart rate variability in healthy and spinal-cord injured subjects: contribution of different complexity-based estimators. IEEE Trans Biomed Eng (2006) 0.90

Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther (2010) 0.90

Determinants of heart rate and heart rate variability. J Hypertens (2003) 0.90

Muscle metaboreflex contribution to cardiovascular regulation during dynamic exercise in microgravity: insights from mission STS-107 of the space shuttle Columbia. J Physiol (2006) 0.90

Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study). Atherosclerosis (2011) 0.90